Characteristics of coronary endothelial dysfunction in experimental diabetes

Cardiovascular Research

Volumn 34, Issue 1, 1997, Pages 157-163

  Koltai, Mária Zsófia ^a   Hadházy, Pál ^b   Pósa, Ildikó ^a   Kocsis, Erzsébet ^a   Winkler, Gábor ^c   Rösen, Peter ^d   Pogátsa, Gábor ^a  

^a National Institute of Cardiology Budapest   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c ST JOHN'S HOSPITAL   (Hungary)

^d LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

Coronary artery; Diabetes; Dog; Nitric oxide; Prostaglandins

Indexed keywords

ACETYLCHOLINE; ALLOXAN; ARGININE; CYCLIC GMP; NITROPRUSSIDE SODIUM; PROSTAGLANDIN SYNTHASE INHIBITOR; PROSTANOID;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CELL MEMBRANE CONDUCTANCE; CONTROLLED STUDY; CORONARY ARTERY; DOG; ENDOTHELIUM LESION; EXPERIMENTAL DIABETES MELLITUS; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; VASODILATATION;

ACETYLCHOLINE; ANIMALS; ARGININE; CORONARY CIRCULATION; CORONARY VESSELS; CYCLIC GMP; CYCLOOXYGENASE INHIBITORS; DIABETES MELLITUS, EXPERIMENTAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; IBUPROFEN; INDOMETHACIN; MALE; NITRIC OXIDE; NITROPRUSSIDE; VASODILATION; VASODILATOR AGENTS;

EID: 0343416823     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00050-3     Document Type: Article

References (31)

1. Glasser SP, Selwyn AP, Ganz P. Atherosclerosis: risk factors and the vascular endothelium. Am Heart J 1996;131:379-384.
2. Furchgott RF. Introduction to EDRF research. J Cardiovasc Pharmacol 1993;22:S1-S2.
3. Moncada S, Higgs A. Mechanisms of disease: the L-arginine nitric oxide pathway. N Engl J Med 1993;329:2002-2012.
4. Delonca J, Balteaux V, Giraud T, Sanchez RY. EDRF/NO and endothelial function. Arch Mal Coeur Vaiss 1993;86:1617-1624.
5. Wennmalm A. Endothelial nitric oxide and cardiovascular disease. J Intern Med 1994;235:317-327.
6. Bassenge E. Clinical relevance of endothelium derived relaxing factor (EDRF). Br J Clin Pharmacol 1992;34:37S-42S.
7. Sikorski BW, Hodgson WC, King RG. Effect of haemoglobin and N-nitro-L-arginine on constrictor and dilator response of aortic rings from streptozotocin diabetic rats. Eur J Pharmacol 1993;242:275-282.
8. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali J. Impairment of coronary vascular reserve and acetyl-choline induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 1993;42:1017-1025.
9. Reddy KG, Nair RN, Sheehan HM, Hodgson JM. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol 1994;23:833-843.
10. Koltai MZ, Wagner M, Pogátsa G. Altered hyperemic response of the coronary arterial bed in alloxan-diabetes. Experientia 1983;39:738-740.
11. Mayhan WG. Impairment of endothelium dependent relaxation of the basilar artery during diabetes mellitus. Brain Res 1992;580:297-302.
12. Langenstroer P, Pieper GM. Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am J Physiol 1992;263:H257-H265.
13. Kamata K, Miyata N, Kasuya Y. Impairment of endothelium dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br J Pharmacol 1989;97:614-618.
14. Chang KS, Stevens WC. Endothelium dependent increase of vascular sensitivity to phenylephrine in long-term streptozotocin diabetic rat aorta. Br J Pharmacol 1992;107:983-990.
15. Way KJ, Reid JJ. Effect of diabetes and elevated glucose on nitric oxide mediated neurotransmission in rat anococcygeus muscle. Br J Pharmacol 1995;115:409-414.
16. Pieper GM, Peltier BA. Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium. J Cardiovasc Pharmacol 1995;25:397-403.
17. Pelligrino DA, Koenig HM, Wang Q, Albracht RF. Protein kinase C suppresses receptor mediated pial arteriolar relaxation in diabetic rat. Neuroreport 1994;5:417-420.
18. Bohlen HG, Lash JM. Topical hyperglycaemia rapidly suppresses EDRF mediated vasodilation of normal rat arterioles. Am J Physiol 1993; 265:H219-H225.
19. Taylor PD, McCarthy AL, Thomas CL, Poston L. Endothelium dependent relaxation and noradrenaline sensitivity in mesenteric resistance arteries of streptozotocin induced diabetic rats. Br J Pharmacol 1992;107:393-399.
20. Craven PA, Studer RK, DeRubertis FR. Impaired nitric oxide dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. J Clin Invest 1994;93:311-320.
21. Rösen P, Ballhausen T, Stockklauser K. Impairment of endothelium dependent relaxation in the diabetic rat heart: mechanisms and implications. Diabetes Res Clin Pract 1996;31:S143-S155.
22. Koltai MZ, Rösen P, Hadházy P, Ballagi-Pordány G, Köszeghy A, Pogátsa G. Relationship between vascular adrenergic receptors and prostaglandin biosyntheses in canine diabetic coronary arteries. Diabetologia 1988;31:6:681-686.
23. 2 synthesis by diabetic coronary arteries. J Diabet Compilc 1988;2:5-7.
24. Imai I, Kolb H, Burkart V. Nitric oxide production from macrophages is regulated by arachidonic acid metabolites. Biochem Biophys Res Commun 1993;197:105-109.
25. Pieper GM, Gross GJ. Differential response of postischaemic myocardium to a thromboxane mimetic. Eicosanoids 1990;3:127-133.
26. Oyama Y, Kawasaki H, Hattori Y, Kanno M. Attenuation of endothelium dependent relaxation in aorta from diabetic rats. Eur J Pharmacol 1986;132:75-78.
27. Cameron NE, Cotter MA. Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway. Diabetologia 1992;35:1011-1019.
28. Taylor PD, Oon BB, Thomas CR, Poston L. Prevention by insulin treatment of endothelial dysfunction but not enhanced noradrenaline-induced contractility in mesenteric resistance arteries from streptozotocin-induced diabetic rats. Br J Pharmacol 1994;111:35-41.
29. Pieper GM, Moore-Hilton G, Roza AM. Evaluation of the mechanisms of endothelial dysfunction in the genetically-diabetic BB-rat. Life Sci 1996;58:PL147-PL152.
30. 2, on isolated coeliac and basilar arteries of alloxan-diabetic dogs. Eur J Clin 1984;14:130-134.
31. Berti F, Rossoni G, Della Bella D, et al. Nitric oxide and prostacyclin influence coronary vasomotor tone in perfused rabbit heart and modulate endothelin-1 activity. J Cardiovasc Pharmacol 1993;22:321-326.